Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $7.1 million.

  • STRATA Skin Sciences' Cash & Current Investments fell 1572.18% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year decrease of 1572.18%. This contributed to the annual value of $8.6 million for FY2024, which is 587.58% up from last year.
  • As of Q3 2025, STRATA Skin Sciences' Cash & Current Investments stood at $7.1 million, which was down 1572.18% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' Cash & Current Investments ranged from a high of $17.5 million in Q1 2021 and a low of $4.2 million during Q1 2023
  • Over the past 5 years, STRATA Skin Sciences' median Cash & Current Investments value was $8.5 million (recorded in 2023), while the average stood at $9.4 million.
  • As far as peak fluctuations go, STRATA Skin Sciences' Cash & Current Investments tumbled by 6167.72% in 2023, and later surged by 5697.56% in 2024.
  • STRATA Skin Sciences' Cash & Current Investments (Quarter) stood at $12.6 million in 2021, then crashed by 46.01% to $6.8 million in 2022, then grew by 19.47% to $8.1 million in 2023, then rose by 5.88% to $8.6 million in 2024, then dropped by 17.67% to $7.1 million in 2025.
  • Its last three reported values are $7.1 million in Q3 2025, $6.0 million for Q2 2025, and $7.8 million during Q1 2025.